Annoucements
-
Sep 12, 2026Announcement on Subsidiary's Receipt of U.S. FDA Approval for an Additional Manufacturing Site for Adalimumab Injection
Learn More
-
Sep 17, 2026
Announcement on the U.S. FDA Approval of the Subsidiary's Insulin Aspart Injection
Learn More
-
Sep 17, 2026
Announcement on the Subsidiary's Receipt of the U.S. FDA Approval for the Manufacturing Site Transfer Registration of Desmopressin Acetate Injection
Learn More
-
Sep 17, 2026
Announcement on the Receipt of the Drug Registration Approval for Propofol Injectable Emulsion from the National Medical Products Administration
Learn More
-
Sep 17, 2026
Announcement on Change in Accounting Policies
Learn More
